{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:22:39Z","timestamp":1774362159619,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.ejphar.2005.02.023","type":"journal-article","created":{"date-parts":[[2005,3,19]],"date-time":"2005-03-19T23:18:26Z","timestamp":1111274306000},"page":"61-66","source":"Crossref","is-referenced-by-count":30,"title":["Effects of solifenacin succinate (YM905) on detrusor overactivity in conscious cerebral infarcted rats"],"prefix":"10.1016","volume":"512","author":[{"given":"Masanori","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"Ohtake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiji","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Yuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aska","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Ukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Okutsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Sasamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2005.02.023_bib1","first-page":"253","article-title":"Pharmacology of lower urinary tract smooth muscles and penile erectile tissues","volume":"45","author":"Andersson","year":"1993","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2005.02.023_bib2","first-page":"279","article-title":"International Union of Pharmacology: XVII. Classification of muscarinic acetylcholine receptors","volume":"50","author":"Caulfield","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2005.02.023_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0165-6147(94)90047-7","article-title":"Muscarinic acetylcholine receptor subtypes in smooth muscle","volume":"15","author":"Eglen","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2005.02.023_bib4","first-page":"531","article-title":"Muscarinic receptor subtypes and smooth muscle function","volume":"48","author":"Eglen","year":"1996","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2005.02.023_bib5","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0024-3205(97)00433-5","article-title":"Subtypes of the muscarinic receptor in smooth muscle","volume":"61","author":"Ehlert","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2005.02.023_bib6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/01.STR.26.4.627","article-title":"Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation","volume":"26","author":"Garcia","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2005.02.023_bib7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/ageing\/23.3.246","article-title":"Cerebral aetiology of urinary urge incontinence in elderly people","volume":"23","author":"Griffiths","year":"1994","journal-title":"Age Ageing"},{"key":"10.1016\/j.ejphar.2005.02.023_bib8","first-page":"40","article-title":"Antimuscarinics for the treatment of overactive bladder: current options and emerging therapies","volume":"5","author":"Hegde","year":"2004","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.ejphar.2005.02.023_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00210-002-0554-x","article-title":"M3 receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland","volume":"366","author":"Ikeda","year":"2002","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.02.023_bib10","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.5980\/jpnjurol1989.87.1221","article-title":"Experimental study of voiding dysfunction induced by cerebral infarction in rats","volume":"87","author":"Ishiura","year":"1996","journal-title":"Jpn. J. Urol."},{"key":"10.1016\/j.ejphar.2005.02.023_bib11","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0022-5347(05)64634-4","article-title":"Effects of selective \u03b22 and \u03b23-adrenoceptor agonists on detrusor hyperreflexia in conscious cerebral infarcted rats","volume":"168","author":"Kaidoh","year":"2002","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2005.02.023_bib12","first-page":"R1230","article-title":"GABAergic contribution to rat bladder hyperactivity after middle cerebral artery occlusion","volume":"279","author":"Kanie","year":"2000","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2005.02.023_bib13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0090-4295(90)80048-R","article-title":"Analysis of voiding disorders in patients with cerebrovascular accidents","volume":"35","author":"Khan","year":"1990","journal-title":"Urology"},{"key":"10.1016\/j.ejphar.2005.02.023_bib14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.lfs.2003.07.019","article-title":"Comparison of in vitro selectivity profiles of solifenacin succinate (YM905) and current antimuscarinic drugs in bladder and salivary glands: a Ca2+ mobilization study in monkey cells","volume":"74","author":"Kobayashi","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2005.02.023_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","article-title":"Reversible middle cerebral artery occlusion without craniectomy in rats","volume":"20","author":"Longa","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2005.02.023_bib16","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1464-410x.1999.00251.x","article-title":"A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence","volume":"84","author":"Madersbacher","year":"1999","journal-title":"BJU Int."},{"key":"10.1016\/j.ejphar.2005.02.023_bib17","first-page":"921","article-title":"Effects of aniracetam on bladder overactivity in rats with cerebral infarction","volume":"293","author":"Nakada","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.02.023_bib18","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0022-5347(05)68348-6","article-title":"Effects of nifedipine on bladder overactivity in rats with cerebral infarction","volume":"162","author":"Nakamura","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2005.02.023_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejphar.2004.03.044","article-title":"In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats","volume":"492","author":"Ohtake","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.02.023_bib20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0302-2838(03)00353-1","article-title":"Effects of tramadol on rat detrusor overactivity induced by experimental cerebral infarction","volume":"44","author":"Pehrson","year":"2003","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2005.02.023_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-0773.1976.tb03167.x","article-title":"The effects of some anticholinergic compounds on the infused urinary bladder of anaesthetized rabbits","volume":"39","author":"Sj\u00f6gren","year":"1976","journal-title":"Acta Pharm. Toxicol."},{"key":"10.1016\/j.ejphar.2005.02.023_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0090-4295(83)90099-7","article-title":"Urodynamic studies on hemiplegic patients after cerebrovascular accident","volume":"21","author":"Tsuchida","year":"1983","journal-title":"Urology"},{"key":"10.1016\/j.ejphar.2005.02.023_bib23","first-page":"959","article-title":"Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins","volume":"273","author":"Wang","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.02.023_bib24","first-page":"R935","article-title":"Glutamatergic and dopaminergic contributions to rat bladder hyperactivity after cerebral artery occlusion","volume":"276","author":"Yokoyama","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2005.02.023_bib25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0028-3908(01)00102-2","article-title":"Forebrain muscarinic control of micturition reflex in rats","volume":"41","author":"Yokoyama","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2005.02.023_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/exnr.2001.7833","article-title":"Changes in dopaminergic and glutamatergic excitatory mechanisms of micturition reflex after middle cerebral artery occlusion in conscious rats","volume":"173","author":"Yokoyama","year":"2002","journal-title":"Exp. Neurol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905001822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905001822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T01:23:28Z","timestamp":1548638608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299905001822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0014299905001822"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2005.02.023","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}